(Vienna, 14 August 2026) Eight research projects involving researchers from MedUni Vienna were successful in the latest Health calls for proposals under the EU’s Horizon Europe research programme and have been invited to prepare their grant agreements. One of the projects is coordinated by MedUni Vienna: Antonia Müller leads the ‘regulAId’ consortium.
MedUni Vienna has achieved an outstanding track record in the 2025 and 2026 Horizon Europe Health calls, making it the most successful organisation in Austria in these calls. A total of eight project proposals involving researchers from MedUni Vienna were invited to the so-called Grant Agreement Preparation stage following a successful evaluation. In this phase, the grant agreements are prepared in collaboration with the European Union. The formal funding decision will be made once these contractual preparations have been finalised. If funding is awarded, these projects will bring over 4.5 million euros to MedUni Vienna’s projects
A broad spectrum of medical research
Three of the new projects stem from the Health Calls 2025. Gilbert Hangel and Georg Widhalm are involved in the BRAIN-EDGE project, whilst Oliver Strobel is involved in the NANOPANTHER project; both fall within the Horizon thematic area covering multinational clinical trials involving medical devices for rare diseases and highly innovative ‘breakthrough devices’, respectively. Oswald Kothgassner and Christian Scharinger are contributing to the MINDSET project, which was successful in the call for proposals on innovative interventions for mental, behavioural and neurodevelopmental disorders.
A further five successful projects stem from the 2026 Health Calls and cover a broad spectrum of current medical challenges. Paul Plener is involved in PROTECT-SH, a project aimed at developing innovative interventions to counter the negative effects of digital technologies on the mental health of children and young adults. Judit Simon is contributing to STRIVE, a project focusing on the health consequences of climate change. Thomas Vogl is involved in the RESTART project, which focuses on the prevention, diagnosis and treatment of long-term health consequences following infections.
Antonia Müller is involved in two successful projects. EXACT-EU was selected in the call for proposals to establish a European network of centres of excellence for Advanced Therapy Medicinal Products (ATMPs). In the regulAId project, which falls under the thematic area of Regulatory Science to support the translational development of patient-centred health technologies, Müller is also coordinating the European consortium.
Müller is Head of the University Clinic for Transfusion Medicine and Cell Therapy at MedUni Vienna and her work focuses, amongst other things, on cell therapies and clinical translation.
Horizon Europe funds cutting-edge European research
Horizon Europe is the European Union’s flagship research and innovation programme. The ‘Health’ cluster supports international research consortia that develop new knowledge and innovative solutions for the prevention, diagnosis and treatment of diseases, as well as for key challenges facing healthcare systems.